ESC 365 - Epigenetic therapy reduces cardiac hypertrophy in murine models of heart failure

Open Access

Epigenetic therapy reduces cardiac hypertrophy in murine models of heart failure

Session: Poster session 3 - Cardiomyopathies and fibrosis

Topic: Cardiomyopathies

Speaker: Doctor A. Russell-Hallinan (Belfast, GB)

Event: Frontiers in CardioVascular Biology 2016

Congress Presentation

Add to my library

About the speaker

Doctor Adam Russell-Hallinan

Queen's University of Belfast, Belfast (United Kingdom of Great Britain & Northern Ireland)

0 follower

11 more presentations in this session

Cardiomyopathies and fibrosis - Poster discussant:

Effects of genetic or pharmacologic inhibition of the ubiquitin/proteasome system on myocardial proteostasis and cardiac function

Suppression of Wnt signalling in a desmoglein-2 transgenic mouse model for arrhythmogenic cardiomyopathy

Speaker: Doctor A. Lorenzon (Padua, IT)

Cold-induced cardiac hypertrophy is reversed after thermo-neutral deacclimatization

Speaker: Miss C. Ruperez (Barcelona, ES)

CD45 is a sensitive marker to diagnose lymphocytic myocarditis in endomyocardial biopsies of living patients and in autopsies

Speaker: Ms L. Woudstra (Amsterdam, NL)

Access the full session

Poster session 3 - Cardiomyopathies and fibrosis

Speakers: Doctor A. Russell-Hallinan, Doctor A. Lorenzon, Miss C. Ruperez, Ms L. Woudstra

About the event

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources